We have some exciting news to share! The Motley Fool UK has now become The Twelfth Magpie -- an independent, UK-owned company, led by our long-serving UK management team — Mark Rogers, Chris Nials and Heather Adlington. In practical terms, it’s the same team you know, now fully focused on serving our UK readers and members.

Just as importantly, our approach remains unchanged: long-term, jargon-free, and on your side. This site is our new home, and there will be extra tweaks made across the coming few days as we settle in. So if anything looks a little off, please bear with us!

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Why I’d buy these 2 FTSE 100 defensive shares today

I think holding FTSE 100 defensives in my investing portfolio is always a good idea. It can keep me safe in times of economic downturns. 

| More on:

You’re reading a free article with opinions that may differ from The Twelfth Magpie’s Premium Investing Services. Become a member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn more, and get a free 'Best Buy Now' stock!.

It is not like I am expecting a recession or even a slowdown. But I do think that it is a good idea to allocate a proportion of my stock investing portfolio to FTSE 100 defensives or safe shares. 

Why buy FTSE 100 defensives

The reason is that economic growth happens in cycles. This means that we should always be prepared for the next phase, and that includes downturns. Moreover, sometimes these come about unpredictably, as we saw last year. 

Should you buy Hikma Pharmaceuticals Plc shares today?

Before you decide, please take a moment to review this report first. Despite ongoing uncertainties from US tariffs to global conflicts, Mark Rogers and his team believe many UK shares still trade at substantial discounts, offering savvy investors plenty of potential opportunities to learn about.

That’s why this could be an ideal time to secure this valuable research – Mark’s analysts have scoured the markets to reveal 5 of his favourite long-term ‘Buys’. Please, don’t make any big decisions before seeing them.

The FTSE 100 index has a number of high-quality defensives to choose from, ranging across sectors from healthcare to technology, that I can choose from today. Here are two of them:

#1. Hikma Pharmaceuticals: robust health

After touching all-time highs in October, drug manufacturer Hikma Pharmaceuticals (LSE: HIK) has now seen a share price fall of 18%. But going by its results, I think that the manufacturer of Covid-19 medication is due for another share price rally. 

For the full year 2020, the company saw a 23% increase in operating profit and its revenues increased as well. It expects to continue making progress in 2021 too. 

A small positive in buying the share is also its dividend payouts. It has a yield of 1.6%, but it is increasing its dividends. 

The flipside here is that its reported earnings per share (EPS) fell by 9% in the year. To me, this makes further increases in dividends unlikely.

Also, I think this FTSE 100 share could take its time to start rising from here. Defensives or safe stocks are less attractive to investors now, as the economic outlook improves. For the long-term, though, it is a buy for me. 

#2. Unilever: back to market crash levels

The consumer staples’ giant Unilever (LSE: ULVR) saw a sharp share price fall early last month after it reported an underwhelming set of financials. Both the company’s revenues and profits fell.

Going by the company’s past resilience however, I see this more as a blip than the start of a trend. This is even more so now that the economy will recover in 2021. 

Importantly, for income investors the 1% decline in its EPS was disappointing too. The Unilever stock did not have a high dividend yield in the past. But after the hit to dividends across the board in 2020, it does look relatively more attractive from the income perspective. It has a yield of 3.6% now, which I think is alright compared to many others. 

The risk to Unilever is that of a slow recovery or if cost pressures mount.

Another poor year for the UK’s consumer giant will tell further on its share price. Investors have made their disappointment with the latest results amply clear already. In the weeks following the results, its share price dropped to the levels seen during last year’s stock market crash. 

The FTSE 100 share has started recovering since, and I am optimistic about its prospects on balance. 

Manika Premsingh has no position in any of the shares mentioned. The Motley Fool UK has recommended Hikma Pharmaceuticals and Unilever. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Close-up as a woman counts out modern British banknotes.
Investing Articles

How to buy growth stocks at below-market prices

Don’t want to pay market prices for growth stocks? Here's a sneaky strategy investors can use to get deals at…

Read more »

CEO Mark Zuckerberg at F8 2019 event
Investing Articles

Are Meta shares at the start of a comeback?

Shares in Meta Platforms have been held back by the firm’s high-risk approach to AI. But is this the moment…

Read more »

UK financial background: share prices and stock graph overlaid on an image of the Union Jack
Investing Articles

With dividend yields averaging above 7%, are these 2 UK shares worth considering?

Muhammad Cheema looks at two UK shares: ITV and Legal & General. With yields of 6.1% and 8.1%, should investors…

Read more »

Close-up as a woman counts out modern British banknotes.
Investing Articles

How much do you need to invest in dividend stocks to be able to retire?

Some 77% of people in the UK won't have enough income to manage a moderate retirement. Here’s how dividend stocks…

Read more »

Abstract bull climbing indicators on stock chart
Investing Articles

FTSE 250 stock CMC’s shares have rocketed 51%! What’s going on?

CMC Markets' shares have surged by double-digits today after a strong full-year trading update. Is the FTSE 250 company now…

Read more »

A row of satellite radars at night
Investing Articles

Will I buy SpaceX at £100 a share in my SIPP?

Ben McPoland is considering adding SpaceX stock to his SIPP on 12 June. Might this be a no-brainer buy-and-hold opportunity?

Read more »

Young brown woman delighted with what she sees on her screen
Investing Articles

Aberdeen shares are back in the FTSE 100 — is this turnaround stock just getting started?

Following its return to the FTSE 100, Andrew Mackie examines whether Aberdeen's shares could be on the cusp of a…

Read more »

Shot of an young mixed-race woman using her cellphone while out cycling through the city
Investing Articles

Down 65% with a 5.65% yield! Is this dividend share a once-in-a-decade buy? 

Harvey Jones says this dividend share is still posting decent profits at a challenging time. Its low valuation and high…

Read more »